Aptevo Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Aptevo Therapeutics has a total shareholder equity of $6.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $17.6M and $11.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$10.25m |
| Equity | US$6.10m |
| Total liabilities | US$11.53m |
| Total assets | US$17.63m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AP8's short term assets ($12.1M) exceed its short term liabilities ($6.3M).
Long Term Liabilities: AP8's short term assets ($12.1M) exceed its long term liabilities ($5.2M).
Debt to Equity History and Analysis
Debt Level: AP8 is debt free.
Reducing Debt: AP8 has no debt compared to 5 years ago when its debt to equity ratio was 49.6%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AP8 has sufficient cash runway for 5 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: AP8 is forecast to have sufficient cash runway for 5 months based on free cash flow estimates, but has since raised additional capital.